SCRIB and breast carcinoma: However, the protein levels of SLC7A11 in ER+ breast cancer cell lines are quite lower than in ER− breast cancer cells (Fig. 4f), suggesting that SCRIB-SLC3A2 complex mainly targets SLC7A5 in ER+ breast cancer cells.